Dr. Lu Tang's lab at the University of Pittsburgh focuses on enhancing the safety and effectiveness of machine learning algorithms in medical decision-making, specifically for sepsis treatment. By analyzing a large dataset from sepsis patients, the lab aims to create algorithms that can provide personalized treatment recommendations while managing risks and uncertainties. The research aims not only to develop novel methods but also to translate these improvements into user-friendly software for practical use in healthcare settings.

Dr. Mark Shlomchik's lab focuses on understanding how memory B cells develop and function, particularly in response to infections and vaccinations. By studying the molecular and cellular processes in germinal centers, which are key sites for antibody production, the lab aims to uncover how our immune system remembers pathogens and generates long-lasting immunity. This research has implications for vaccine design and understanding various immune-related diseases.

Dr. Jason Shoemaker's research focuses on understanding how the hormone estradiol affects immune responses during influenza infection, and how these effects differ between male and female biological subjects. His lab utilizes mathematical modeling and experimental methods to identify immune mechanisms influenced by estradiol. This research could lead to improved treatments tailored to individual hormonal levels and biological sex.

Dr. Richard E. Debski's lab focuses on understanding and improving exercise therapy for individuals with rotator cuff tears, particularly in older adults. Their research investigates how personalized exercise programs can help restore shoulder function and prevent the need for surgery, aiming to enhance patient outcomes and develop effective clinical guidelines for treatment. By analyzing biomechanical and clinical factors over time, the lab seeks to create individualized rehabilitation strategies for better long-term results.

Dr. Jennifer Silk's research focuses on understanding how social experiences, both online and in-person, affect the mental health of adolescent girls. She aims to identify the factors that increase the risk of suicidal thoughts and behaviors, as well as depression, by studying girls' interactions and feelings in real-time. By combining psychological assessments with brain imaging and machine learning techniques, her work seeks to find ways to prevent mental health crises among youth.

Dr. Harinder Singh's lab at the University of Pittsburgh focuses on understanding how the immune system, particularly B cells and T follicular helper (TFH) cells, responds to influenza vaccinations in children. The lab uses advanced genomic and immunological techniques to analyze the effectiveness of vaccines and aims to identify the molecular factors that lead to durable antibody responses, potentially improving vaccine strategies.

Dr. Aatur Dilip Singhi's lab at the University of Pittsburgh focuses on understanding non-functional pancreatic neuroendocrine tumors (NF-PanNETs), which are complex and varied tumors that can behave aggressively. The research aims to identify new biomarkers that can help predict how these tumors grow and spread. By studying the genetic and epigenetic changes that occur in these tumors, the lab hopes to improve patient outcomes through better prognostic tools and understanding of tumor behavior.

Dr. Patricia L. Opresko's lab at the University of Pittsburgh focuses on understanding how environmental factors, such as oxidative stress, impact telomeres—structures at the ends of chromosomes that are crucial for maintaining genome stability. The lab employs innovative techniques to induce specific DNA damage at telomeres in various models, including cell cultures and transgenic animals, to study the resulting effects on cellular and organismal health. The ultimate goal is to develop strategies that can either protect healthy cells from damage or inhibit tumor growth in cancerous cells.

Dr. Amantha Thathiah's lab at the University of Pittsburgh focuses on understanding Alzheimer's disease, particularly how specific cell types in the brain react to the disease. They study a protein called GPR3, which might influence brain inflammation and cognitive decline in Alzheimer's patients. By investigating how GPR3 affects brain cells like microglia and neurons, the lab hopes to find new, safer treatments for Alzheimer's.

Dr. Yan Dong's lab focuses on understanding how specific brain cells, called astrocytes, influence behaviors related to cocaine addiction. They examine how cocaine changes the connectivity in certain brain regions, particularly how these changes can lead to cravings and relapse. By studying these processes, the lab aims to uncover potential new treatment strategies for dealing with addiction.

Dr. Rebecca A. Elsner's lab focuses on understanding the extrafollicular B cell response, which plays a key role in our immune defense but is often overlooked. The lab explores how this response is regulated and its implications for diseases like lupus and COVID-19. By investigating the interaction of B cells with other immune cells, and how they differentiate in response to certain signals, the research aims to uncover new strategies for vaccine development and treatments for autoimmune conditions.

Dr. Kirill Kiselyov's lab at the University of Pittsburgh focuses on understanding how neuronal cells die in Alzheimer's disease, particularly the role of a protein called GDAP1 in protecting against oxidative damage. The lab investigates the relationship between GDAP1 levels and a harmful compound known as 4-hydroxynonenal (4HNE), which accumulates in the brains of Alzheimer's patients. By studying cellular mechanisms in neuronal models, the lab aims to uncover potential therapeutic strategies for Alzheimer's disease.

Dr. Haitao Guo's lab at the University of Pittsburgh focuses on understanding chronic hepatitis B virus (HBV) infection, which affects millions of people worldwide. They investigate the role of hepatitis B e antigen (HBeAg) in the body's inability to clear HBV, which contributes to serious liver conditions like cirrhosis and liver cancer. By exploring the biological processes related to HBV persistence, their work aims to develop new treatment strategies for this public health challenge.

Dr. Jing Hong Wang's lab at the University of Pittsburgh focuses on understanding how head and neck cancer that is associated with human papillomavirus (HPV) responds to immunotherapy. The team studies the immune system's reaction to HPV antigens and how different T cell receptors impact treatment effectiveness. Their research aims to improve therapies for patients with HPV-positive cancers by exploring the mechanisms driving treatment resistance and response.

Dr. Riyue Bao's lab at the University of Pittsburgh focuses on understanding how certain tumors evade immune therapy, particularly in head and neck cancer. By investigating the role of a specific molecular target, p38 MAPK, the lab aims to improve cancer treatments. Using advanced techniques and large patient data sets, the research seeks to establish new therapeutic strategies that could help re-engage the immune system against tumors.

The research lab led by Dr. Lawrence P. Kane at the University of Pittsburgh focuses on understanding how certain immune cells regulate the body's response to cancer. By studying proteins like Tim-3 and their interaction with other immune pathways, the lab aims to develop more effective immunotherapies for solid tumors. The ultimate goal is to enhance the immune system's ability to fight cancer by targeting specific immune cells and pathways.

Dr. Sina Tavakoli's lab focuses on improving the diagnosis and treatment of lung diseases, especially those related to inflammation and fibrosis. The lab is exploring innovative imaging techniques to assess immune responses in the lungs, particularly looking at a specific protein (CMKLR1) that is crucial in these diseases. By developing new molecular imaging tools, the lab aims to offer better precision in tracking disease progression and responses to treatments, ultimately enhancing patient care.

Dr. Eliza C. Miller's lab at the University of Pittsburgh focuses on understanding how complications during pregnancy, such as high blood pressure or preterm birth, relate to the risk of developing Alzheimer's disease in mothers later in life. By using data from a large study of pregnant women and advanced brain imaging techniques, the lab aims to uncover biological pathways that link these pregnancy outcomes to brain health.

Dr. Aaron Paul Batista's lab at the University of Pittsburgh focuses on understanding how the brain controls movement and how memories related to motor skills are formed and stored. By using brain-computer interfaces, the lab investigates the dynamics of neural population activity during tasks involving memory and movement, with the goal of developing new therapeutic strategies for stroke recovery and cognitive enhancement. Their research aims to provide better treatment options for neurological disorders through innovative tools that adjust neural patterns in real-time.

Dr. Edwin S. Levitan's lab at the University of Pittsburgh focuses on understanding how neuropeptides, which are small protein-like molecules, help regulate important behaviors such as sleep and circadian rhythms. The lab uses advanced imaging techniques to study how these neuropeptides are released in the brain and how their release is influenced by different signals. This research is critical for revealing how neuropeptides contribute to the functioning of the nervous system, especially during behavioral changes and plasticity.